BioRender

BioRender

Private
Toronto, OntarioHealthcare & Life Scienceshttps://www.biorender.com

Last Round

Growth Equity

Dec 18, 2025

Est. Valuation

$900M

Total Funding Raised

$45.12M

Company Overview

BioRender is a technology company that offers a science illustration software enabling users to create custom visuals for effective communication and presentation of scientific research.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Content Creation, Data Visualization

Business Model

B2B

Customer Profile

Freemium, Subscription SaaS

AI Layer

Application

Keywords

scientific illustration softwareCanva for scientistslife science illustrationscientific icon libraryscientific figure creationscientific templatesscience communicationfreemium SaaSproduct-led growthPLGdrag-and-drop editorbiotech softwareacademic postersAI illustrationClaude integrationsingle sign-onSSO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioRender Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BioRender Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Growth EquityDec 18, 2025
Series BMar 21, 2022
SeedMar 21, 2018

Key People

Founding team and executive leadership

Katya Shteyn

Co-founder And CTO

Founding Team

Shiz Aoki

Co-founder And CEO

Founding Team

BioRender Investors

Notable investors and investment history

InvestorRounds
Refactor CapitalSeed
TCVSeries B
Inovia CapitalSeries B
DimensionGrowth Equity
Real VenturesSeries B
Y CombinatorSeries B, Seed
DimensionGrowth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2026

    Reached over one million scientists using the platform.

  • Mar 5, 2026

    Appeared in over 54,000 scientific publications.

BioRender Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BioRender Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioRender's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto, Ontario
Employee Range225
Year Founded2017
Last FundingDec 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.